Recombinant protein of human g
lycerophosphodiester phosphodiesterase domain containing 2 (GDPD2)- ￥2900
- OriGene
- TP304415
- 2026年03月05日
企业认证
相关产品推荐更多 >
Recombinant protein of human major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2)
￥2900Recombinant protein of human chromosome 1 open reading frame 59 (C1orf59), transcript variant 1
￥2900
Purified recombinant protein of Mouse sorting nexin 16 (Snx16), with C-terminal MYC/DDK tag, expressed in HEK293T cells, 20ug
￥2900
Recombinant protein of human IL2-inducible T-cell kinase (ITK), 20 µg
￥2900Recombinant protein of human fibroblast growth factor receptor 3 (FGFR3), transcript variant 1, 20 µg
￥2900
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Store at -80°C.
- 保质期：
Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.
- 英文名：
Recombinant protein of human glycerophosphodiester phosphodiesterase domain containing 2 (GDPD2)
- 供应商：
OriGene
- 规格：
20 ug
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Characterization and Applications of Plant-Derived Recombinant Antibodies
(3 ). ScFvs have also been expressed in plant-suspension cultures at levels of 0.5% total soluble protein (10 ). The feasibility of expressing and targeting recombinant antibodies (rAbs) (11 ,12 ) has been achieved in different compartments of plants
human E-cadherin-IgG Fc domain fusion protein (E-cad-Fc) has recently been shown to be extremely efficient in facilitating the culture of human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells under completely defined conditions
Expression and Isolation of Recombinant Antibody Fragments in E. coli
linker into expression constructs to produce scFv. Further variants include the addition of a range of suitable (C-terminal) tags for the purification or detection of expressed protein, such as a human Cκ domain (scAb) (2 ), c-myc, or hexahistidine.
技术资料暂无技术资料 索取技术资料
